RAPT Therapeutics (RAPT) Shares Outstanding (Weighted Average): 2020-2024
Historic Shares Outstanding (Weighted Average) for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $4.4 million.
- Therapeutics' Shares Outstanding (Weighted Average) rose 1.63% to $4.4 million in Q4 2024 from the same period last year, while for Sep 2024 it was $4.4 million, marking a year-over-year increase of 1.59%. This contributed to the annual value of $4.4 million for FY2024, which is 1.63% up from last year.
- According to the latest figures from Q4 2024, Therapeutics' Shares Outstanding (Weighted Average) is $4.4 million, which was up 0.16% from $4.4 million recorded in Q3 2024.
- Over the past 5 years, Therapeutics' Shares Outstanding (Weighted Average) peaked at $4.4 million during Q4 2024, and registered a low of $3.0 million during Q1 2020.
- In the last 3 years, Therapeutics' Shares Outstanding (Weighted Average) had a median value of $4.3 million in 2023 and averaged $4.1 million.
- Data for Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 20.51% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Therapeutics' Shares Outstanding (Weighted Average) stood at $3.1 million in 2020, then climbed by 20.32% to $3.7 million in 2021, then increased by 1.23% to $3.7 million in 2022, then rose by 15.00% to $4.3 million in 2023, then rose by 1.63% to $4.4 million in 2024.
- Its Shares Outstanding (Weighted Average) was $4.4 million in Q4 2024, compared to $4.4 million in Q3 2024 and $4.4 million in Q2 2024.